DIA 2013 49th Annual Meeting
Click here to go to the previous page
GCP and Inspection Readiness
Track : Track 11: Innovative Approaches to Ensuring Compliance with Good Clinical Practice (GCP) and Quality Assurance (QA)
Program Code: 215
Date: Tuesday, June 25, 2013
Time: 8:00 AM to 9:30 AM  EST
Location: 156AB
CHAIR :
 Marta Haley Fields, MBA (SCHNON), Senior Director, Compliance and Quality Systems, Seattle Genetics, Inc., United States
SPEAKER (S):
 Cynthia Kleppinger, MD (SPKAGY), Senior Medical Officer, Office of Scientific Investigations, CDER, FDA, United States
Marta Haley Fields, MBA (SPKNON), Senior Director, Compliance and Quality Systems, Seattle Genetics, Inc., United States
 Donna W. Dorozinsky, MSN,RN (SPKNON), President, DWD & Associates, Inc., United States
Description
While strict compliance with good clinical practice is the best preparation for a regulatory inspection, even the most compliant sponsors and clinical sites view the possibility of an inspection with fear and trepidation. Having a toolkit for managing inspections can go a long way to reducing those concerns. The FDA and EMA have different inspectional approaches and require different means of preparation.

This session will explore those differences and propose alternative methods to approach each experience.